OsanetantAlternative Names: SR 142801; SR 142806
Latest Information Update: 05 Sep 2005
At a glance
- Originator sanofi-aventis
- Class Antipsychotics; Anxiolytics; Piperidines
- Mechanism of Action Neurokinin 3 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder; Schizophrenia